Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Mitochondria-specific nanotechnology.

Weissig V, Boddapati SV, Jabr L, D'Souza GG.

Nanomedicine (Lond). 2007 Jun;2(3):275-85. Review.

PMID:
17716174
2.

Pivotal role of nanotechnologies and biotechnologies for molecular imaging and therapy.

Lucignani G.

Eur J Nucl Med Mol Imaging. 2006 Jul;33(7):849-51. Review. No abstract available.

PMID:
16758195
3.

Less than perfect divorces: dysregulated mitochondrial fission and neurodegeneration.

Oettinghaus B, Licci M, Scorrano L, Frank S.

Acta Neuropathol. 2012 Feb;123(2):189-203. doi: 10.1007/s00401-011-0930-z. Epub 2011 Dec 17. Review.

PMID:
22179580
4.

Targeted drug delivery to mammalian mitochondria in living cells.

Weissig V.

Expert Opin Drug Deliv. 2005 Jan;2(1):89-102. Review.

PMID:
16296737
5.

[Mitochondrial diseases in children including Leigh syndrome--biochemical and molecular background].

Pronicka E, Piekutowska-Abramczuk D, Pronicki M.

Postepy Biochem. 2008;54(2):161-8. Review. Polish.

PMID:
18807927
6.

Mitochondrial diseases.

Schapira AH.

Lancet. 2012 May 12;379(9828):1825-34. doi: 10.1016/S0140-6736(11)61305-6. Epub 2012 Apr 5. Review.

PMID:
22482939
7.

[Mitochondria in cell life, death and disease].

Wojtczak L, Zabłocki K.

Postepy Biochem. 2008;54(2):129-41. Review. Polish.

PMID:
18807924
8.

Biochips beyond DNA: technologies and applications.

Ng JH, Ilag LL.

Biotechnol Annu Rev. 2003;9:1-149. Review.

PMID:
14650926
9.

Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosis.

Brooks C, Cho SG, Wang CY, Yang T, Dong Z.

Am J Physiol Cell Physiol. 2011 Mar;300(3):C447-55. doi: 10.1152/ajpcell.00402.2010. Epub 2010 Dec 15.

10.

Age related mitochondrial degenerative disorders in humans.

Reeve AK, Krishnan KJ, Turnbull DM.

Biotechnol J. 2008 Jun;3(6):750-6. doi: 10.1002/biot.200800066. Review.

PMID:
18512864
11.

Yeast models of human mitochondrial diseases: from molecular mechanisms to drug screening.

Schwimmer C, Rak M, Lefebvre-Legendre L, Duvezin-Caubet S, Plane G, di Rago JP.

Biotechnol J. 2006 Mar;1(3):270-81. Review.

PMID:
16897707
12.

Mitochondrial-targeted drug and DNA delivery.

Weissig V.

Crit Rev Ther Drug Carrier Syst. 2003;20(1):1-62. Review.

PMID:
12911263
13.

Quality control of mitochondria: protection against neurodegeneration and ageing.

Tatsuta T, Langer T.

EMBO J. 2008 Jan 23;27(2):306-14. doi: 10.1038/sj.emboj.7601972. Review.

14.

How mitochondrial damage affects cell function.

James AM, Murphy MP.

J Biomed Sci. 2002;9(6 Pt 1):475-87. Review.

PMID:
12372986
15.

Nanotechnology: convergence with modern biology and medicine.

Roco MC.

Curr Opin Biotechnol. 2003 Jun;14(3):337-46. Review.

PMID:
12849790
16.

Mitochondrion and its related disorders: making a comeback.

Zhang XN, Qi M.

J Zhejiang Univ Sci B. 2008 Feb;9(2):90-2. doi: 10.1631/jzus.B0710621. Review.

17.

Delivery to mitochondria: a narrower approach for broader therapeutics.

Malhi SS, Murthy RS.

Expert Opin Drug Deliv. 2012 Aug;9(8):909-35. doi: 10.1517/17425247.2012.694864. Epub 2012 Jun 5. Review.

PMID:
22663303
18.

VDAC, a multi-functional mitochondrial protein as a pharmacological target.

Shoshan-Barmatz V, Ben-Hail D.

Mitochondrion. 2012 Jan;12(1):24-34. doi: 10.1016/j.mito.2011.04.001. Epub 2011 Apr 20. Review.

PMID:
21530686
19.

Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria.

Yamada Y, Akita H, Kogure K, Kamiya H, Harashima H.

Mitochondrion. 2007 Feb-Apr;7(1-2):63-71. Epub 2006 Dec 13. Review.

PMID:
17296332
20.

Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases.

Yamada Y, Harashima H.

Adv Drug Deliv Rev. 2008 Oct-Nov;60(13-14):1439-62. doi: 10.1016/j.addr.2008.04.016. Epub 2008 Jul 4. Review.

PMID:
18655816

Supplemental Content

Support Center